The Goldman Sachs Group Lowers Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target to $40.00

Retrieved on: 2023-11-12 17:16:24

Tags for this article:

Click the tags to see associated articles and topics

The Goldman Sachs Group Lowers Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target to $40.00. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 3,514,356 shares of the company's stock worth $98,929,000 after acquiring an additional 2,520,355 shares during the last ...

Article found on: www.defenseworld.net

View Original Article